Pantoprazole: all 120 studies that test it
Page 1 of 2. Open to participants first (6), then studies with results posted, then the rest; newest registration first within each.
- A Study to Compare How CHF10196 (Florensocatib) is Absorbed Into the Blood When Given Alone and With a Drug That Reduces Stomach Acid in Healthy Male ParticipantsNot yet recruitingNCT07683793Phase 1
- Pantoprazole After Prophylactic Endoscopic Variceal TreatmentEnrolling by invitationNCT07248722Not applicable
- PPIs and In-Hospital Morbidity in Acute Variceal Bleeding With Chronic Liver DiseaseRecruitingNCT06861478Phase 2
- Post-Cardiac Surgery Acute Kidney Injury Prevention by Administration of Proton Pump Inhibitor (P2 Trial)RecruitingNCT06706258Phase 2
- Comparison of Early Proton Pump Inhibitor Initiation Versus Usual Care on Acute Kidney Injury in Hemorrhagic Shock PatientsRecruitingNCT06531642Phase 2/3
- Preoperative Use of Pantoprazole for Prevention of Post Operative Nausea and Vomiting in Gynecologic SurgeryRecruitingNCT06488001Phase 2
- Prevention of Post-Cardiac Surgery Acute Kidney Injury by Proton Pump InhibitorCompletedNCT06154226Phase 2Results posted
- Role of Proton Pump Inhibitors on the Postoperative Course Following PancreaticoduodenectomyTerminatedNCT05251233Phase 2Results posted
- Effect of Obesity on Proton Pump InhibitorsCompletedNCT04248335Phase 4Results posted
- Comparison of Hybrid and Bismuth Quadruple Therapies for Helicobacter Pylori EradicationCompletedNCT02541864Not applicableResults posted
- Stress Ulcer Prophylaxis in the Intensive Care UnitCompletedNCT02467621Phase 4Results posted
- PREA, PK And Safety PASS Study Of IV Pantoprazole In Pediatric SubjectsTerminatedNCT02401035Phase 4Results posted
- Comparison of 12-day Reverse Hybrid Therapy and 12-day Standard Triple Therapy for Helicobacter Pylori InfectionCompletedNCT02359435Not applicableResults posted
- Optimal Dose of Proton Pump Inhibitors Following an Upper Gastrointestinal BleedTerminatedNCT02235311Not applicableResults posted
- PK Study With Pantoprazole in Obese Children and AdolescentsCompletedNCT02186652Phase 1Results posted
- Pharmacokinetics of Pantoprazole and CYP2C19 Activity in Children and Adolescents With GERD: A Pilot StudyCompletedNCT01887743Phase 1Results posted
- Preventing Nephrotoxicity and Ototoxicity From Osteosarcoma TherapyCompletedNCT01848457Phase 2Results posted
- Influence of Pantoprazole on the Bioavailability of MMF and EC-MPSCompletedNCT01801280Phase 4Results posted
- Comparison of Pantoprazole and Ranitidine in DyspepsiaCompletedNCT01737840Phase 4Results posted
- Pantoprazole on Insulin Secretion in DiabetesCompletedNCT01541735Phase 2/3Results posted
- Structured Non-operative Treatment of Knee OsteoarthritisCompletedNCT01535001Not applicableResults posted
- A Prospective, Open Label Study Evaluating Two Management Strategies on Gastrointestinal Symptoms in Patients Newly on Treatment With Pradaxa for the Prevention of Stroke and Systemic Embolism With Non-valvular Atrial FibrillationCompletedNCT01493557Phase 4Results posted
- Enteral Nutrition as Stress Ulcer Prophylaxis in Critically Ill Patients.CompletedNCT01477320Not applicableResults posted
- Symptomatic Relief of Acute Dyspeptic Pain in Emergency Department With PantoprazoleCompletedNCT01281501Phase 4Results posted
- Drug-Drug Interaction of Cladribine and Pantoprazole in Multiple Sclerosis SubjectsCompletedNCT00938366Phase 1Results posted
- Open Label Safety Study of Enteric-Coated Spheroid Suspension in Infants Aged Less Than 12 Months With Presumed Gastroesophageal Reflux Disease (GERD)CompletedNCT00868296Phase 3Results posted
- Pantoprazole Sodium 40 mg DR Tablets Under Fasting ConditionsCompletedNCT00835588Phase 1Results posted
- Incretin Effect and Use After Clinical Islet TransplantationCompletedNCT00768651Phase 2Results posted
- Rapid Screening Phenotype Test To Evaluate CYP 2C19 Enzyme Activity Using Stable Isotope [13C]PantoprazoleCompletedNCT00668902Not applicableResults posted
- Study Evaluating the Efficacy and Safety of Pantoprazole in Infants With Symptomatic Gastroesophageal Reflux Disease (GERD)CompletedNCT00365300Phase 3Results posted
- Study Evaluating Pantoprazole in Neonates and Preterm Infants With GERDCompletedNCT00362609Phase 3Results posted
- Gastroprotective Efficacy of Rebamipide in Patients With Atrial Fibrillation Treated With DOACsCompletedNCT07354230Phase 4
- Pharmacokinetics of Clozapine and Norclozapine and the Effect of PantoprazoleCompletedNCT07262736Phase 1
- Efficacy of Vonoprazan in Eradication of Resistant Strain of Helicobacter PyloriCompletedNCT06414707Phase 3
- Quadruple vs Tailored Therapy in the Treatment of Helicobacter Pylori InfectionCompletedNCT04621487Not applicable
- Effect of Proton Pump Inhibitor of Daily Use for One Month on Kidney Function TestStatus unknownNCT04022837Phase 2
- Pantoprazole Prophylaxis Against Delayed CINV for Patients Receiving Breast Cancer ChemotherapyCompletedNCT03948477Phase 2
- Effect of Daily Use Proton Pump Inhibitors for One Month on Kidney FunctionStatus unknownNCT03910647Phase 2
- Proton Pump Inhibitor Preventing Upper Gastrointestinal Injury In Patients On Dual Antiplatelet Therapy After CABGActive, not recruitingNCT03908593Phase 4
- Esomeprazole or Pantoprazole in Renal TransplantationCompletedNCT03812419Not applicable
- PPI and Microbiome in Healthy Volunteers and Functional DyspepsiaCompletedNCT03545243Phase 4
- Re-EValuating the Inhibition of Stress Erosions (REVISE) TrialCompletedNCT03374800Phase 3
- Drug/Drug Interactions With F901318WithdrawnNCT03095547Phase 1
- Proton Pump Inhibitor Prevent Dual Antiplatelet Agents Induced Gastrointestinal Ulcer After Coronary Artery Bypass GraftWithdrawnNCT03038009Phase 4
- Pediatric Intensive Care Ulcer Prophylaxis Pilot TrialCompletedNCT02929563Phase 3
- Sup-Icu RENal (SIREN)CompletedNCT02718261Phase 4
- Impact of Pantoprazole on 24-H Glycemic Control and on Post-prandial Glucose Excursion in Patients With Type 2 DiabetesStatus unknownNCT02345239Phase 3
- Re-Evaluating the Inhibition of Stress Erosions: Gastrointestinal Bleeding Prophylaxis In ICUCompletedNCT02290327Phase 3
- Influence of Pantoprazole on the Pharmacokinetics of Fradafiban After Multiple Oral Doses of Lefradafiban in Healthy SubjectsCompletedNCT02264119Phase 1
- Influence of Pantoprazole on the Pharmacokinetics of Fradafiban After Multiple Oral Doses of Lefradafiban Over 5 Days in Healthy SubjectsCompletedNCT02264106Phase 1
- A Multiple Dose Study of Debio 1450 [Intravenous (IV) and Oral] in Healthy VolunteersCompletedNCT02214433Phase 1
- Study of the Effects of Pantoprazole on Levels of Prescribed Psychiatric MedicationsWithdrawnNCT02213887Phase 4
- Bioavailability of Oral BIRB 796 BS Tablets With and Without Administration of Oral Pantoprazole in Healthy Male VolunteersCompletedNCT02209831Phase 1
- BIBR 953 ZW in Healthy Elderly SubjectsCompletedNCT02173730Phase 1
- Bioavailability of BIBR 963 ZW After 50 mg of BIBR 1048 MS With and Without of Pantoprazole in Healthy SubjectsCompletedNCT02170896Phase 1
- Assessment of Safety, Pharmacokinetics and the Effect of BIBR 1048 MS on Coagulation Parameters in Healthy Volunteer SubjectsCompletedNCT02170740Phase 1
- Bioavailability of BIBR 953 ZW After Oral Administration of BIBR 1048 MS in Healthy SubjectsCompletedNCT02170636Phase 1
- Bioavailability of BIBR 953 ZW After Administration of BIBR 1048 MS in Healthy SubjectsCompletedNCT02170623Phase 1
- Bioavailability of BIBR 1048 MS With and Without Pantoprazole Under Influence of Food in Healthy SubjectsCompletedNCT02170610Phase 1
- The Study of Eustachian Tube Dysfunction and Laryngopharyngeal RefluxWithdrawnNCT02123498Phase 4
- "Pharmacodynamic Comparison of Omeprazole Versus Pantoprazole on Platelet Reactivity in Patients With Acute Coronary Syndromes on Dual Antiplatelet Therapy With New P2Y12 Inhibitors" -Trial dOPPLER-Status unknownNCT02028234Phase 4
- Comparative Bioavailability Study of Two Test Products of Fixed Dose Combination Capsule of ASA (Acetylsalicylic Acid) and Pantoprazole (Each Capsule Contains ASA 100 mg and Pantoprazole 20 mg) Under Fasting ConditionsCompletedNCT01847404Phase 1
- Pantoprazole and Docetaxel for Men With Metastatic Castration-Resistant Prostate CancerCompletedNCT01748500Phase 2
- Indomethacin Prophylaxis for Heterotopic Ossification After Surgical Treatment of Elbow TraumaStatus unknownNCT01744314Not applicable
- Omeprazole and Pantoprazole Antiplatelet Effect of Clopidogrel Clinical Trials(OPEN)Status unknownNCT01735227Phase 4
- Clinical Study, Multicenter, Randomized With 2 Arms of Pantoprazole + Domperidone and Pantoprazole Isolated at the Gastroesophageal Reflux DiseaseWithdrawnNCT01710462Phase 3
- Evaluation of Two Therapies for the Treatment of Osteoarticular Inflammation in Dyspeptic PatientsCompletedNCT01670552Phase 3
- Bioequivalence Study of Pantoprazole Sodium 40 mg Delayed Release Tablets Fed StudyCompletedNCT01654718Not applicable
- Bioequivalence Study of Pantoprazole Sodium 40 mg Delayed Release Tablets Fasting StudyCompletedNCT01654705Not applicable
- The Efficacy of Pantoprazole Treatment in Patients With Functional DyspepsiaStatus unknownNCT01608750Phase 4
- Proton Pump Inhibitors in the Prevention of Iron Reaccumulation in Patient With Hereditary HemochromatosisStatus unknownNCT01524757Not applicable
- Magnesium Pantoprazole 20mg b.i.d. vs Magnesium Pantoprazole 40mg q.d. on Intragastric Acid InhibitionWithdrawnNCT01499693Phase 3
- Bioequivalence Study of Pantoprazole Sodium DR Tablets 40 mg of Dr. Reddy's Laboratories Limited Under Fed ConditionCompletedNCT01283932Phase 1
- Bioequivalence Study of Pantoprazole Sodium DR Tablets 40 mg of Dr. Reddy's Laboratories Limited Under Fasting ConditionCompletedNCT01283919Phase 1
- Bioequivalence Study of Pantoprazole 40 mg DR Tablets and Protonix 40 mg Tablets Under Fed ConditionsCompletedNCT01179659Phase 1
- Bioequivalence Study of Pantoprazole 40 mg DR Tablets and Protonix 40 mg TabletsCompletedNCT01179646Phase 1
- Pantoprazole With Doxorubicin for Advanced Cancer Patients With Extension Cohort of Patients With Solid TumoursCompletedNCT01163903Phase 1
- Pantoprazole Magnesium 40 mg Versus Esomeprazole 40 mg in Patients With Erosive Gastroesophageal Reflux DiseaseCompletedNCT01132638Phase 3
- EVL (Endoscopic Variceal Ligation) Plus Vasoconstrictor vs.Ligation Plus PPI( Proton Pump Inhibitor) in the Control of Acute Esophageal Variceal BleedingCompletedNCT01112852Phase 4
- Clopidogrel Proton-Pump Inhibitors StudyWithdrawnNCT01016717Phase 4
- Platelet Inhibitory Effect of Clopidogrel in Patients Treated With Omeprazole, Pantoprazole, or FamotidineCompletedNCT00950339Phase 4
- Symptom Evaluation After Cessation of a Proton Pump Inhibitor in Healthy VolunteersCompletedNCT00915239Not applicable
- Prevention of Esophageal Variceal RebleedingStatus unknownNCT00863837Phase 4
- Famotidine Compared With Pantoprazole to Prevent Recurrent Aspirin-Induced Peptic Ulcer/ErosionCompletedNCT00843063Phase 4
- Comparison of Intravenous Pantoprazole and Famotidine for Stress Ulcer ProphylaxisTerminatedNCT00839488Phase 4
- Pantoprazole Sodium 40 mg DR Tablets Under Non-Fasting ConditionsCompletedNCT00835393Phase 1
- Intravenous (IV) Pantoprazole for Gastroesophageal Reflux Disease (GERD) in Neonates and InfantsCompletedNCT00744419Phase 1
- Intravenous Proton Pump Inhibitor for Peptic Ulcer BleedingCompletedNCT00731601Phase 4
- Effectiveness of the Eradication of Helicobacter Pylori and an Inhibitor of Pump With Proton Versus ControlWithdrawnNCT00713947Phase 4
- High Dose Versus Standard Dose Proton Pump Inhibitor (PPI) in High-risk Bleeding Peptic Ulcers After Combined Endoscopic TreatmentStatus unknownNCT00709046Not applicable
- Influence of Pantoprazole on Human Myocardial Contractility at Patients With Congestive Heart FailureWithdrawnNCT00699361Phase 3
- A Comparative Study of Proton-pump Inhibitor Tests for Chinese Reflux Patients in Relation to the CYP2C19 GenotypesCompletedNCT00681005Not applicable
- Effect of Pantoprazole 40mg Daily vs Placebo on Power Spectral Analysis of the Sleep EEG of Patients With GERD.CompletedNCT00674245Phase 2/3
- A Randomized, Open-Label, Comparative 3-Way Treatment Crossover Study of 24-Hour Intragastric pH Profile of Once Daily Oral Administration of Esomeprazole 40mg, Lansoprazole 30mg, and Pantoprazole 40mg at Steady State in NSAID-Using PatientsCompletedNCT00625274Phase 4
- Placebo-Controlled Crossover Study for the Investigation of the Effect of Pantoprazole on Cardiac ContractilityCompletedNCT00600041Phase 1
- The CONQUEST-Study. Evaluation of Clinical Endpoints for Treatment-induced Changes in GERD-related Symptoms (BY1023/NL511)TerminatedNCT00449813Phase 4
- Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERDCompletedNCT00410592Phase 4
- Study Comparing 2 Different Formulations of Pantoprazole in Healthy Adults.CompletedNCT00383916Phase 1
- Study Evaluating Pantoprazole in Adolescents With GERDCompletedNCT00367614Phase 3
- Symptom Assessment in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) or enGERD (Endoscopic-negative GERD) After Treatment With Pantoprazole (BY1023/M3-343)CompletedNCT00336219Phase 3